JP2019524890A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524890A5
JP2019524890A5 JP2019530369A JP2019530369A JP2019524890A5 JP 2019524890 A5 JP2019524890 A5 JP 2019524890A5 JP 2019530369 A JP2019530369 A JP 2019530369A JP 2019530369 A JP2019530369 A JP 2019530369A JP 2019524890 A5 JP2019524890 A5 JP 2019524890A5
Authority
JP
Japan
Prior art keywords
composition
nucleic acid
raav
promoter
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019530369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524890A (ja
JP7165410B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/047589 external-priority patent/WO2018035451A1/en
Publication of JP2019524890A publication Critical patent/JP2019524890A/ja
Publication of JP2019524890A5 publication Critical patent/JP2019524890A5/ja
Priority to JP2022111264A priority Critical patent/JP7653150B2/ja
Application granted granted Critical
Publication of JP7165410B2 publication Critical patent/JP7165410B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019530369A 2016-08-19 2017-08-18 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物 Active JP7165410B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022111264A JP7653150B2 (ja) 2016-08-19 2022-07-11 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662377297P 2016-08-19 2016-08-19
US62/377,297 2016-08-19
PCT/US2017/047589 WO2018035451A1 (en) 2016-08-19 2017-08-18 Methods and compositions for treating conditions using recombinant self-complementary adeno-associated virus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022111264A Division JP7653150B2 (ja) 2016-08-19 2022-07-11 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2019524890A JP2019524890A (ja) 2019-09-05
JP2019524890A5 true JP2019524890A5 (https=) 2020-12-24
JP7165410B2 JP7165410B2 (ja) 2022-11-04

Family

ID=61197123

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019530369A Active JP7165410B2 (ja) 2016-08-19 2017-08-18 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物
JP2022111264A Active JP7653150B2 (ja) 2016-08-19 2022-07-11 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022111264A Active JP7653150B2 (ja) 2016-08-19 2022-07-11 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物

Country Status (9)

Country Link
US (2) US11207382B2 (https=)
EP (1) EP3500278B1 (https=)
JP (2) JP7165410B2 (https=)
KR (2) KR102759317B1 (https=)
CN (1) CN109843306A (https=)
AU (1) AU2017313844B2 (https=)
CA (1) CA3073137A1 (https=)
ES (1) ES2982489T3 (https=)
WO (1) WO2018035451A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7165410B2 (ja) 2016-08-19 2022-11-04 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物
KR20190088561A (ko) * 2016-12-07 2019-07-26 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 인터류킨-1 수용체 길항제(IL-1RA) cDNA
SI3740222T1 (sl) 2018-01-17 2023-11-30 Meiragtx Uk Ii Limited Modificiran kapsidni protein raav za gensko terapijo
WO2020112853A1 (en) * 2018-11-28 2020-06-04 Genascence Corporation Methods and compositions for treating osteoarthritis
CN113728108A (zh) 2019-02-15 2021-11-30 桑格摩生物治疗股份有限公司 用于生产重组aav的组合物和方法
MX2022000551A (es) * 2019-07-15 2022-05-18 Meiragtx Uk Ii Ltd Proteínas de la cápside de aav modificadas para el tratamiento de una enfermedad artrítica.
WO2021138559A1 (en) * 2019-12-31 2021-07-08 Swanbio Therapeutics Limited Improved aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn)
AU2024332181A1 (en) 2023-08-31 2026-02-12 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026064428A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026064444A1 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156304A (en) 1990-12-20 2000-12-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education Gene transfer for studying and treating a connective tissue of a mammalian host
US5747072A (en) * 1993-07-30 1998-05-05 University Of Michigan Adenoviral-mediated gene transfer to synovial cells in vivo
WO1995016353A1 (en) * 1993-12-14 1995-06-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Systemic gene treatment of connective tissue diseases
US5756283A (en) 1995-06-05 1998-05-26 The Trustees Of The University Of Pennsylvania Method for improved production of recombinant adeno-associated viruses for gene therapy
US6040183A (en) 1995-06-07 2000-03-21 University Of North Carloina At Chapel Hill Helper virus-free AAV production
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
WO1998010087A1 (en) 1996-09-06 1998-03-12 Trustees Of The University Of Pennsylvania Chimpanzee adenovirus vectors
US6548286B1 (en) 1997-04-14 2003-04-15 Cell Genesys, Inc. Methods for increasing the efficiency of recombinant AAV product
WO1999014354A1 (en) 1997-09-19 1999-03-25 The Trustees Of The University Of The Pennsylvania Methods and vector constructs useful for production of recombinant aav
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
AU780231B2 (en) 1998-11-10 2005-03-10 University Of North Carolina At Chapel Hill, The Virus vectors and methods of making and administering the same
US6943153B1 (en) 1999-03-15 2005-09-13 The Regents Of The University Of California Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
DK1180159T3 (da) 1999-05-28 2008-11-17 Targeted Genetics Corp Fremgangsmåder og sammensætninger til at sænke niveauet af Tumor-Nekrose-Faktor (TNF) i TNF-associerede lidelser
US6429001B1 (en) 2000-01-26 2002-08-06 Chiron Corporation Recombinant AAV packaging systems
ATE318923T1 (de) 2000-06-01 2006-03-15 Univ North Carolina Doppelsträngige parvovirus-vektoren
DE10056210A1 (de) 2000-11-13 2002-05-29 Arimedes Biotechnology Gmbh Virales Expressionssystem
JP2004519230A (ja) * 2001-02-06 2004-07-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 低減された免疫原性を有する修飾されたインターロイキン−1受容体アンタゴニスト(il−1ra)
KR100472297B1 (ko) 2001-09-27 2005-03-07 주식회사 두산 리소인지질의 수용성 조성물
KR100471942B1 (ko) 2002-03-19 2005-03-09 주식회사 에스원 복합형 카드와 카드정보 등록 제어시스템
DE10318048A1 (de) 2003-04-17 2004-11-04 Axaron Bioscience Ag Nicht fluoreszierende, durch Proteolyse zur Fluoreszenz aktivierbare Reporterproteine und ihre Verwendung zur Detektion Protease-abhängiger Ereignisse
US8529885B2 (en) 2003-09-01 2013-09-10 Academisch Medisch Centrum AAV vectors for in vivo gene therapy of rheumatoid arthritis
US20070009899A1 (en) 2003-10-02 2007-01-11 Mounts William M Nucleic acid arrays for detecting gene expression in animal models of inflammatory diseases
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
JP5136766B2 (ja) 2004-12-15 2013-02-06 ユニバーシティ オブ ノース カロライナ アット チャペル ヒル キメラベクター
US7943374B2 (en) * 2005-08-21 2011-05-17 Markus Hildinger Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
FR2891544A1 (fr) 2005-09-30 2007-04-06 Genethon Ass Loi De 1901 Substrat proteique pour la detection de l'activite calpaine 3
WO2007112001A2 (en) 2006-03-23 2007-10-04 Caritas St. Elizabeth Medical Center Of Boston, Inc. Compositions and methods for treating myocardial infarction
JP2009534394A (ja) 2006-04-21 2009-09-24 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 結合組織障害の治療
US20080187576A1 (en) * 2006-06-16 2008-08-07 University Of Florida Research Foundation, Inc. Methods for treating articular disease or dysfunction using self-complimentary adeno-associated viral vectors
US20080166762A1 (en) 2006-09-27 2008-07-10 Reliance Life Science Pvt.Ltd. HETEROLOGOUS PRODUCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST (IL-1Ra) IN PICHIA PASTORIS
US7452696B2 (en) 2006-10-27 2008-11-18 National Taiwan University Recombinant plasmid and method for expressing hepatitis B viral antigens and virions in vivo
CN101711164B (zh) 2007-01-18 2014-06-04 密苏里-哥伦比亚大学 可修复肌纤维膜中的神经元型一氧化氮合酶的合成小/微-抗肌萎缩蛋白基因
GB0708376D0 (en) * 2007-05-01 2007-06-06 Alligator Bioscience Ab Novel polypeptides and uses thereof
EP2358733B1 (en) * 2008-11-17 2015-07-08 Inovio Pharmaceuticals, Inc. Antigens that elicit immune response against flavivirus and methods of using same
US9610363B2 (en) 2009-04-16 2017-04-04 President And Fellows Of Harvard College Methods for inhibiting starvation of a cell
JP2013506005A (ja) 2009-09-29 2013-02-21 ギリアド バイオロジクス,インク. 眼の繊維症の処置のための方法及び組成物
DE202009017772U1 (de) 2009-12-10 2011-04-21 Orthogen Ag Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid
EP2394667A1 (en) 2010-06-10 2011-12-14 Laboratorios Del Dr. Esteve, S.A. Vectors and sequences for the treatment of diseases
WO2012047093A1 (en) 2010-10-05 2012-04-12 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Treatment of the sjögren's syndrome
US8883134B2 (en) 2010-10-20 2014-11-11 Handok Pharmaceuticals, Inc. Human interleukin-1 receptor antagonist—hybrid Fc fusion protein
US8736207B2 (en) 2011-01-03 2014-05-27 General Electric Company Method and system for power conversion
MX341578B (es) 2011-02-08 2016-08-25 Abbvie Inc Tratamiento de la osteoartritis y del dolor.
US20130021786A1 (en) 2011-07-21 2013-01-24 Noble Matthew D Utility bag lighting
DK2623604T3 (da) 2012-02-02 2015-06-01 Baylor College Medicine Adenovirusbaseret biologisk afgivelses- og ekspressionssystem til anvendelse ved behandling af osteoartrose
US9254311B2 (en) * 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
WO2013151665A2 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
EP2660325A3 (en) 2012-05-02 2014-02-12 Christian Medical College AAV vectors and corresponding nucleotide sequences and methods
CN103509100B (zh) * 2012-06-15 2017-10-27 上海百迈博制药有限公司 一种白细胞介素‑1受体拮抗剂突变体
US9624282B2 (en) 2012-11-26 2017-04-18 The Curators Of The University Of Missouri Microdystrophin peptides and methods for treating muscular dystrophy using the same
ES2802878T3 (es) 2013-01-25 2021-01-21 Baylor College Medicine Un sistema de administración y expresión de terapia génica adenoviral dependiente de linfocitos T colaboradores
EP2792742A1 (en) 2013-04-17 2014-10-22 Universitätsklinikum Hamburg-Eppendorf (UKE) Gene-therapy vectors for treating cardiomyopathy
CA2909706C (en) 2013-04-17 2023-02-14 Genzyme Corporation Use of an il17 inhibitor for treating and preventing macular degeneration
DE102013215817A1 (de) 2013-08-09 2015-02-12 Universitätsklinikum Hamburg-Eppendorf Neue peptide mit spezifität für die lunge
SI3702466T1 (sl) 2013-08-27 2023-04-28 Research Institute At Nationwide Children's Hospital Proizvodi in postopki za zdravljenje amiotrofične lateralne skleroze
WO2015044292A1 (en) 2013-09-26 2015-04-02 Universitat Autonoma De Barcelona Gene therapy compositions for use in the prevention and/or treatment of non-alcoholic fatty liver disease
DE102013220859B4 (de) 2013-10-15 2016-09-08 Plasmidfactory Gmbh & Co. Kg Minicircles mit viralen Expressionskassetten und ihre Verwendung zur Transformation von Zellen zur Erzeugung rekombinanter Viren oder viraler Genvektoren
US9534225B2 (en) 2014-04-15 2017-01-03 Applied Genetic Technologies Corporation Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (RPGR)
DE102014207498A1 (de) 2014-04-17 2015-10-22 Universitätsklinikum Hamburg-Eppendorf Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark
LT3137497T (lt) 2014-05-02 2021-07-26 Genzyme Corporation Aav vektoriai, skirti tinklainės ir cns genų terapijai
WO2018035441A1 (en) 2016-08-19 2018-02-22 Colorado State University Research Foundation Methods and compositions for treating equine conditions using recombinant self-complementary adeno-associated virus
JP7165410B2 (ja) 2016-08-19 2022-11-04 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド 組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物
EP3500279A4 (en) 2016-08-19 2020-04-22 Calimmune, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANINE CONDITIONS USING A RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS.
KR20190088561A (ko) 2016-12-07 2019-07-26 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 인터류킨-1 수용체 길항제(IL-1RA) cDNA

Similar Documents

Publication Publication Date Title
JP2019524890A5 (https=)
JP7389040B2 (ja) 遺伝子治療のための修飾rAAVキャプシドタンパク質
Balakrishnan et al. Basic biology of adeno-associated virus (AAV) vectors used in gene therapy
AU2001255575B2 (en) Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
US20190292250A1 (en) Aav-anti-vegf for treating cancer in companion animals
BR112020017348A2 (pt) Vetores de vírus adenoassociados (aav), vetores de aav tendo desamidação de capsídeos reduzida e usos dos mesmos
JP2021512072A5 (https=)
AU2001255575A1 (en) Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
JP2003526377A (ja) キメラキャプシドベクターの製造
US20240216543A1 (en) Microdystrophin gene therapy administration for treatment of dystrophinopathies
CN111876432B (zh) 一组肝靶向新型腺相关病毒的获得及其应用
JP2024054398A (ja) 糖原病iiiの処置のためのミニgde
Tang et al. AAV-directed muscular dystrophy gene therapy
US20200318080A1 (en) Methods and compositions for treating equine conditions using recombinant self-complementary adeno-associated virus
KR20230159837A (ko) 21-하이드록실라제 결핍에 대한 유전자 요법
US20250207126A1 (en) Modified muscle-specific promoters
Bulaklak et al. Therapeutic advances in musculoskeletal AAV targeting approaches
JP2024515902A (ja) 組織向性が改善されたアデノ随伴ウイルスベクターカプシド
WO2018035457A1 (en) Methods and compositions for treating canine conditions using recombinant self-complementary adeno-associated virus
US20220204574A1 (en) Production of large-sized quasidystrophins using overlapping aav vectors
CN112011571A (zh) 一种用于治疗脊髓性肌萎缩的基因治疗药物
US20240425879A1 (en) Compositions and methods for adeno-associated (aav) virus dnase expression
EP4680741A2 (en) Exon skipping gene therapy constructs, vectors and uses thereof
TW202603165A (zh) 用於治療杜興氏肌肉失養症之腺相關病毒組成物
HK40049102B (zh) 用於治疗杜兴肌营养不良的组合物和方法